Artivion (AORT) Divestments (2016 - 2017)
Artivion (AORT) posted Divestments of $740000.0 for Q1 2017, down 96.26% on a QoQ basis from $19.8 million in Q1 2016, and down 96.26% year-over-year from $19.8 million in Q1 2016.
Artivion (AORT) Divestments (2016 - 2017) Analysis & Trends
Artivion's Divestments history runs 2 years deep, the most recent figure standing at $740000.0 for Q1 2017.
- Quarterly Divestments fell 96.26% year-over-year to $740000.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $740000.0 (down 96.26% YoY) and the FY2017 annual result came in at $740000.0, down 96.26% from the prior year.
- Divestments was $740000.0 for Q1 2017 at Artivion, down from $19.8 million in the prior quarter.
- Across five years, Divestments topped out at $19.8 million in Q1 2016 and bottomed at $740000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | 9.37 Mn |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 740,000.00 |
| Mar 31, 2016 | 19.80 Mn |